You have read all your free articles, to continue reading subscribe to read the rest of this content.
Alligator Bioscience has entered into a joint research collaboration with MacroGenics to develop novel immunotherapy. The research collaboration will lead to the expansion of Alligator’s patient specific immunotherapy Neo-X-Prime by incorporating MacroGenics’ DART and TRIDENT multi-specific pAlready a subscriber Login You have read all your free articles, to continue reading…
Orexo has announced the submission of a New Drug Application to the US Food and Drug Administration for its lead pharmaceutical pipeline asset, OX124, a nasal rescue medication for opioid overdose. OX124, is based on Orexo's drug delivery platform amorphOX and contains a high-dose of naloxone. Already a subscriber Login…
Xbrane Biopharma and AGC Biologics, a global Biopharmaceutical CDMO, have entered into an agreement to manufacture Xcimzane, a Cimzia biosimilar candidate, for clinical development. Under terms of the agreement, the companies will work together to upscale the established Xcimzane manufacturing prAlready a subscriber Login You have read all your free…
The company has successfully raised 5.5 million SEK in a new share issue and welcomed four new investors to the company. The added investments make it possible for the company to now initiate its planned activities to develop recombinant plasminogen for treatment of diabetic foot ulcers, the compAlready a subscriber…
